Recent Finacing
Recent Raise
Pyramid Biosciences develops targeted therapeutics that modulate TRK receptors, advancing an oral, brain-penetrant TRK inhibitor for resistant solid and brain tumors and a selective TRK modulator for dermatologic inflammation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
